Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China · Delayed Price · Currency is CNY 30.99
-0.16 (-0.51%)
Jan 22, 2026, 3:00 PM CST
Revenue by Product
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Active Pharmaceutical Ingredients and Intermediates - Cardiovascular | 432.01M | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Cardiovascular Growth | 43.81% | Log In | Log In | Log In | Log In | Upgrade |
Finished Drugs | 220.02M | Log In | Log In | Log In | Log In | Upgrade |
Finished Drugs Growth | 144.87% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Anti-Tumor | 211.73M | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Anti-Tumor Growth | -13.31% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Respiratory System | 190.72M | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Respiratory System Growth | 16.80% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Women's Health | 126.31M | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Women's Health Growth | -33.11% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Trade Products | 111.39M | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Trade Products Growth | 5.81% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Other | 86.93M | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Other Growth | 24.28% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Nervous System | 68.09M | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Nervous System Growth | -7.46% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Anti-infection | 24.86M | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates - Anti-infection Growth | 34.49% | Log In | Log In | Log In | Log In | Upgrade |
Other | 3.67M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -57.28% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | - | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Overseas | 1.15B | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | 4.64% | Log In | Log In | Log In | Log In | Upgrade |
China | 330.45M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 96.64% | Log In | Log In | Log In | Log In | Upgrade |